CHICAGO A new study sheds light on how the mosquito-borne Zika virus causes a rare neurological condition, and the findings could have implications for companies working on Zika vaccines, U.S. researchers said on Wednesday.
Video: What is Zika?
CHICAGO A Zika vaccine Sanofi SA dropped in September under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported on Monday.
Advisers to the U.S. Food and Drug Administration on Friday recommended that the requirements for screening blood donations for the Zika virus be relaxed due to diminished risk of transfusion-transmitted infection.
LONDON Japan's Takeda Pharmaceutical has moved ahead in the race to develop a vaccine for the mosquito-borne Zika virus, with the start of a clinical trial program backed by the U.S. government.
CHICAGO A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea's GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday.
CHICAGO A single genetic change that occurred in 2013 may explain how Zika acquired the ability to attack fetal nerve cells, causing a severe birth defect in babies whose mothers were infected while pregnant, Chinese and U.S. researchers reported on Thursday.
TEPIC, Mexico (Thomson Reuters Foundation) - A new “dipstick” serum test to quickly and cheaply determine whether a person is infected with Zika could lead to better healthcare for women with the virus, which can cause birth defects, said scientists.
CHICAGO American technology companies are bringing automation and robotics to the age-old task of battling mosquitoes in a bid to halt the spread of Zika and other mosquito-borne maladies worldwide. | Video
SINGAPORE Singapore on Friday confirmed two cases of locally transmitted infections of the mosquito-borne Zika virus, bringing the total number of reported cases in the city-state this year to eight.
Puerto Rico on Monday declared that the 2016 Zika epidemic is over, saying transmission of the virus that can cause birth defects when pregnant women are exposed has fallen significantly.
NEW DELHI India has reported cases of the Zika virus, the World Health Organization said, adding that efforts should be made to strengthen surveillance.
CHICAGO Studies using gene sequencing equipment to trace the path of Zika through the Americas show the virus arrived a year before the first case was detected in Brazil, and several months before it was first reported in Florida.
LONDON Scientists in Britain plan to harness the Zika virus to try to kill brain tumor cells in experiments that they say could lead to new ways to fight an aggressive type of cancer.
HAVANA Cuba said on Thursday 1,847 residents had so far contracted the mosquito-borne Zika virus, warning that certain provinces on the Caribbean island still had high rates of infestation despite a series of measures to stave off the epidemic.
Austrian biotech company Themis Bioscience said on Tuesday it had started a clinical trial of an experimental Zika vaccine in healthy volunteers, opening up another front in the race to prevent the spread of the mosquito-borne disease.
CHICAGO Texas health officials are expanding testing recommendations for pregnant women in South Texas as the advent of warm weather increases the risk for local transmission of the mosquito-borne virus that has been shown to cause severe birth defects.
TEPIC, Mexico (Thomson Reuters Foundation) - The ripple effects of the Zika virus are hitting the poor hard in Latin America and the Caribbean, and could knock back development unless states involve communities in a stronger push to tackle the disease, a U.N.-led study said on Thursday.
CHICAGO About one in 10 pregnant women with confirmed Zika infections had a fetus or baby with birth defects, offering the clearest picture yet of the risk of Zika infection during pregnancy, U.S. researchers said on Tuesday.
CHICAGO Researchers have begun the second phase of testing of a Zika vaccine developed by U.S. government scientists in a trial that could yield preliminary results as early as the end of 2017.
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) said on Friday that vaccinations have begun in a mid-stage trial testing an experimental DNA vaccine for Zika.